Association between serum soluble ST2 concentrations and congestion assessed by the Rohde score in patients with acute decompensated chronic heart failure
Main Article Content
Abstract
Congestion is a hallmark clinical manifestation and a crucial prognostic factor in patients with acute decompensated chronic heart failure. However, its accurate clinical assessment remains challenging. This prospective cohort study was conducted on 79 patients to determine the association between serum soluble ST2 (sST2) concentrations and congestion quantified by the Rohde score. The results showed that the prevalence of clinical congestion (Rohde score ≥ 5) was 48.1%. The mean serum sST2 concentration was 28.26 ± 8.27 ng/mL. Multivariate logistic regression analysis demonstrated that every 5 ng/mL increase in sST2 levels was associated with a 1.33-fold increase in the risk of severe congestion (OR = 1.33; 95% CI: 1.02 - 1.82; p = 0.048). These findings confirm that sST2 is an independent factor reflecting congestion burden and mechanical stress, providing additive value to clinical assessment.
Article Details
Keywords
sST2, acute decompensated chronic heart failure, congestion, Rohde score
References
2. Hội Tim mạch học Việt Nam. Cập nhật 2024 của Hội Tim mạch học Việt Nam về chẩn đoán và điều trị suy tim (Bổ sung Khuyến cáo 2022 của Hội Tim mạch Quốc gia Việt Nam về chẩn đoán và điều trị Suy tim cấp và Suy tim mạn). 2024.
3. Nguyễn Quang Trung, Nguyễn Hoàng Anh, Đinh Tấn Quỳnh, và cs. Đặc điểm và kết cục ngắn hạn của người bệnh nhập viện vì suy tim mất bù cấp tại Bệnh viện Nhân dân Gia Định. Tạp chí Y học Việt Nam. 2024;542(3)doi:10.51298/vmj.v542i3.11213
4. Kim MS, Jeong TD, Han SB, et al. Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency. Journal of Korean medical science. 2015;30(5):569-75. doi:10.3346/jkms.2015.30.5.569
5. Rohde LE, Beck-da-Silva L, Goldraich L, et al. Reliability and prognostic value of traditional signs and symptoms in outpatients with congestive heart failure. The Canadian journal of cardiology. 2004;20(7):697-702.
6. Savarimuthu S, Goel P, Harky A. Soluble ST2: a valuable prognostic marker in heart failure. Heart failure reviews. 2022;27(6):2155-2164. doi:10.1007/s10741-022-10258-2
7. Breidthardt T, Balmelli C, Twerenbold R, et al. Heart failure therapy-induced early ST2 changes may offer long-term therapy guidance. Journal of cardiac failure. 2013;19(12):821-8. doi:10.1016/j.cardfail.2013.11.003
8. Bayes-Genis A, Zamora E, de Antonio M, et al. Soluble ST2 serum concentration and renal function in heart failure. Journal of cardiac failure. 2013;19(11):768-75. doi:10.1016/j.cardfail.2013.09.005
9. Pascual-Figal DA, Manzano-Fernández S, Boronat M, et al. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. European journal of heart failure. 2011;13(7):718-25. doi:10.1093/eurjhf/hfr047
10. Dương Hồng Niên, Nguyễn Xuân Tiện, Lưu Quang Minh, và cs. Vai trò tiên lượng tái nhập viện và tử vong của nồng độ sST2 huyết thanh ở bệnh nhân suy tim mạn tính. Journal of 108 - Clinical Medicine and Phamarcy. 2023;18(6):33-38. doi:doi.org/10.52389/ydls.v18i6.2012
11. Espriella R, Bayés-Genis A, Revuelta-Ló PE, et al. Soluble ST2 and Diuretic Efficiency in Acute Heart Failure and Concomitant Renal Dysfunction. Journal of cardiac failure. 2021;27(4):427-434. doi:10.1016/j.cardfail.2020.10.002
12. Manzano-Fernández S, Mueller T, Pascual-Figal D, et al. Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction. The American journal of cardiology. 2011;107(2):259-67. doi:10.1016/j.amjcard.2010.09.011